GE Deal With Danaher Shows Culp Is All About the Balance Sheet - Bloomberg
GE sells BioPharma business to CEO's former company for $21.4 billion | CNN Business
GE sells biopharma unit for $21 billion | The Seattle Times
Debt-saddled GE sells off BioPharma business to Danaher for $21.4B - MedCity News
GE agrees to sell BioPharma unit to Danaher for US$21.4 billion
GE sells jet-leasing unit to AerCap for $30 bn
GE sells biopharma drug business to Danaher for $21.4 bn, Energy News, ET EnergyWorld
GE to sell biopharma business to Danaher for $21B - Boston Business Journal
GE: The Biopharma Deal Is Nearing Completion
General Electric — Wikipédia
GE To Sell Its BioPharma Unit For $21.4 Billion To Danaher | GE News
GE To Sell Its BioPharma Unit For $21.4 Billion To Danaher | GE News
GE chief Larry Culp sells biopharma business for $21 billion
GE to Sell Its Biotech Business to Danaher for $21 Billion - WSJ
GE sells biopharma unit for US$21 billion | CTV News
General Electric Sells Biopharma Unit for $21 Billion | | 2news.com
How to Trade GE Stock After Earnings Surge - TheStreet
GE sells BioPharma business to CEO's former company
GE sells BioPharma business to CEO's former company for $21.4 billion | CNN Business
GE to Sell Its Biotech Business to Danaher for $21 Billion - WSJ
GE To Sell Biopharma Business For $21.4bn – Independent Newspaper Nigeria
GE sells its biopharma business to Danaher for $21.4 billion
GE Sells Coveted BioPharma Unit to Pay Down $21 Billion in Crippling Debt
GE Sells Coveted $21 Billion BioPharma to Pay Down Crippling Debt Load
Baxter sells Biopharma Solutions unit for $4.25B | BioWorld
Danaher absorbing GE's bioprocess biz in $21.4bn deal - BioProcess InternationalBioProcess International
GE sells biopharma drug business to Danaher for $21.4 billion
GE Healthcare leaves GE, looks to 'next chapter'
Danaher Selling Off Some Businesses to Sartorius for $750M, Tying the Deal to GE Biopharma Acquisition
